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We have isolated and cultured three distinct adenoviruses from wild gorillas. Phylogenetic analysis
grouped the viruses with human adenovirus species C based on DNA polymerase, hexon, and E4ORF6
genes. The three wild gorilla adenoviruses clustered with the other species C captive gorilla adeno-
viruses, forming a branch separate from human and chimpanzee/bonobo adenoviruses. Animal sera to
the three newly isolated viruses did not cross-neutralize, demonstrating serological distinctiveness. The
human adenovirus 5 ﬁber knob blocked infection, suggesting use of the Coxsackie and Adenovirus
Receptor. These viruses may provide viral vectors with properties distinct from chimpanzee adenovirus
and human adenovirus vectors.
& 2013 Elsevier Inc. All rights reserved.Introduction
Adenoviruses are double-stranded DNA, non-enveloped viruses
that have signiﬁcant utility as gene transfer vectors. Adenovirus
vaccine vectors elicit antibody and cellular responses to encoded
antigens, are safe in people, and have commercial feasibility
(Barouch and Nabel, 2005). Vectors derived from species C
adenoviruses (Ad5, Ad6, ChAd3) have been the most immunogenic
(Capone et al., 2006; Colloca et al., 2012). However, immunity in
the general population has limited the broad application of Ad
vectored-vaccines based upon Ad5 while rare human adenoviruses
have been less immunogenic than Ad5 (Abbink et al., 2007;
Colloca et al., 2012). Vaccine vectors based on non-human adeno-
viruses do not face pre-existing immunity in the general popula-
tion (Farina et al., 2001; Hofmann et al., 1999; Reddy et al., 1999).
Gorilla adenoviruses have been detected by PCR of wild gorilla
specimens (Roy et al., 2009; Wevers et al., 2011) and isolated from
captive gorillas (Roy et al., 2009; Wevers et al., 2010). Here we
describe the discovery of three adenoviruses cultured from gorillas
with limited human contact.ll rights reserved.Results and discussion
Virus isolation
Fecal samples were obtained from healthy wild Mountain
(Gorilla beringei beringei) and Grauer's (Gorilla beringei graueri,
formerly known as Eastern Lowland) gorillas cared for at the
Eastern Gorilla Interim Quarantine Facility, Kinigi, Rwanda. Due to
the limited contact between humans and the gorillas, the risk of
cross zootic recombination was minimized, compared to what
might occur with animals raised in captivity. Approximately 0.1 g
of fecal matter was dissolved in DMEM, clariﬁed by labtop
centrifugation at 2600 rpm for 5 min, passed through a 0.2 μ ﬁlter,
and added to 293-ORF6 cells (E1 and E4 complementing human
cells (Brough et al., 1996)) in 48 well plates. The 293-ORF6 cell line
was used to select gorilla adenoviruses that could grow on a
human cell line that was appropriate for use as a cell substrate in
the manufacturing of adenovirus vectors for human clinical testing
(Butman et al., 2006). The plate was centrifuged for 90 min in a
Beckman Coulter 6KR centrifuge at 2900 rpm, and the medium
exchanged with DMEM+5% FBS+100 mM ZnCl2. Five days post-
infection the culture was harvested and used to re-infect
293-ORF6 cells as above until CPE was observed. When CPE was
observed the cultures were harvested, treated by chloroform
extraction, added to fresh cell cultures, and used to re-infect
293-ORF6 cells. Adenovirus was conﬁrmed by PCR ampliﬁcation
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by sequencing the hexon gene. From the fecal specimens, three
viruses were cultured and the three had distinct hexon sequences.
The virus GC44 was isolated from a 6 year-old Mountain Gorilla,
and viruses GC45 and GC46 from different 7 year-old Grauer's
gorillas. Following the naming convention described in Wevers
et al. (2011), these viruses would be named Gorilla beringei beringei
adenovirus 7 isolate GC44, Gorilla beringei graueri adenovirus
8 isolate GC45, and Gorilla beringei graueri adenovirus 9 isolate
GC46. Interestingly, since this group of animals was not exposed to
other gorillas since being orphaned it would suggest that wild
great apes become infected at a young age and the virus can
persist as part of the commensal ﬂora in the animal's digestive
track. Alternatively, viral infection is cleared but the virus was
transmitted from one gorilla to the next.
The three gorilla adenovirus genomes were cloned into bacteria
to isolate the viruses from helper effects and contaminants from
the original fecal specimen. Each virus genome was cloned into a
plasmid using homologous recombination in bacteria, followingFig. 1. Phylogenetic reconstructions. Relationships were inferred using the Maximum
(A) DNA polymerase, (B) E4 34K, and (C) hexon. The human adenovirus species C bran
together in the bootstrap test (100 replicates) are shown next to the branches, with non-
31.2, SAdV-34, SAdV-40.2, SAdV-40.1, SAdV-42.3, SAdV-42.2, SAdV-42.1, SAdV-44; additpreviously described protocols (Chartier et al., 1996; McVey et al.,
2002, 2010). The genome-containing plasmids were then puriﬁed
by three serial rounds of limiting-dilution DNA transformation and
colony isolation in bacteria. The identities of the plasmid-cloned
genomes were conﬁrmed by DNA sequencing. The genes for DNA
polymerase, E4ORF6 encoding the Ad5 34k protein homolog, and
hexon were sequenced and were identical to sequences of the
originally cultured viruses. Lastly, to verify the integrity of the
cloned genomes, viruses were rescued back from the cloned
genomes by transfection of 293-ORF6 cells and serial passaging
(McVey et al., 2002).Phylogeny
Phylogenetic reconstruction was conducted with MEGA5
(Tamura et al., 2011) based on multiple sequence alignment and
Maximum Likelihood method with the TN93 substitution model
for protein-coding nucleotide sequences (Tamura and Nei, 1993).Likelihood method with the TN93 substitution model for nucleotide sequences of
ch is in blue. Percentage of replicate trees in which the associated taxa clustered
signiﬁcant values not shown. Chimpanzee/bonobo viruses: (A)–(C) SAdV-31.1, SAdV-
ionally for (C) PtroAdV-9, PtroAdV-6, and PtroAdV-4.
Fig. 2. GC viruses with deletions of E1A and E1B are replication-deﬁcient. Cells
were infected with 5 FFU/cell, harvested 72 h post-infection, freeze/thawed three
times, and the FFU titers of the cell-virus lysates were determined. GC46
wt¼plasmid-cloned GC46 virus; ΔE1¼plasmid-cloned viruses with deletion of
E1A and E1B with a luciferase expression cassette inserted at the deletion junction;
dashed line¼ limit of quantitation 2.03105 FFU/mL. Data are averages7standard
deviation for n¼3 technical replicates (GC46) or single data points (GC44
and GC45).
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representative genomes for each of the human species including
B1 and B2, and an outgroup sequence, Bovine Adenovirus 3 (BAdV-
3). This preliminary analysis showed that all three gorilla adeno-
viruses were most similar to human adenovirus species C (unpub-
lished data). Phylogenetic reconstructions were then conducted with
the human adenoviruses, BAdV-3, and all gorilla, chimpanzee, and
bonobo adenovirus sequences previously classiﬁed within human
adenovirus species C and were available in GenBank (Colloca et al.,
2012; NCBI, 2013; Roy et al., 2004, 2011, 2009; Wevers et al., 2010,
2011). See the “Sequence accession numbers” section for all
sequences used. Phylogenetic reconstructions based on the DNA
polymerase gene and the E4 34k gene placed all three gorilla
adenoviruses within human adenovirus species C (Fig. 1A and B).
The consistent clustering of GC44, GC45, and GC46 based on two
genes located close to opposite termini of the linear adenovirus
genome suggests the absence of cross-zootic recombination. Adeno-
viruses are often compared on hexon protein sequence because the
presence of hypervariable regions allows for identiﬁcation of poten-
tially unique adenoviruses. Phylogenetic reconstruction based on
hexon amino acid sequence revealed that the three gorilla adeno-
viruses were most closely related to the human species C adeno-
viruses (Fig. 1C), consistent with the DNA polymerase and E4 34K
protein trees. The addition of these three species C gorilla adeno-
viruses to the phylogenetic reconstructions of adenovirus species C
allowed for further inference of the evolutionary history. The gorilla
adenoviruses clustered as a branch distinct from the human and
chimpanzee/bonobo viruses, implying there has been no recent
horizontal transmission between host species.Fig. 3. Inhibition of cellular infection by hAd5 ﬁber knob. HEK293 cells were
incubated with (open bar) and without (dark bar) hAd5 ﬁber knob before being
infected with hAd5, GC46 and hAd35 luciferase expressing viruses. Data shown are
means +/−SEM.Serology
Although signiﬁcant type determining epitopes are in the hexon
protein, there are also type-speciﬁc epitopes in the ﬁber protein, thus
the sequence analysis of hexon is not sufﬁcient to predict whether
two viruses are serologically distinct. Therefore, heterologous neu-
tralizing titers were determined with a luciferase-based assay (Kahl
et al., 2010) using gorilla adenoviruses engineered to express lucifer-
ase from the E1 region. BALB/c mice were immunized with 109
particle units (pu) of cesium chloride-gradient puriﬁed wild type
virus on day 0 and 8 weeks and serum collected 14 days later. Animal
studies were approved by the Institutional Animal Care and Use
Committee of GenVec, Inc., and in compliance with policies as
outlined in the “NIH Guide for the Care and Use of Laboratory
Animals” and the Public Health Service “Policy on Humane Care
and Use of Laboratory Animals.” Virus (2000 pu) was mixed with
two-fold serial dilutions of mouse sera starting at 1:16. Homologous
titers were high and sera did not neutralize heterologous viruses
(Table 1); thus, the three viruses are serologically distinct from each
other. The identiﬁcation of three distinct adenoviruses from these
wild gorillas is novel and suggests that adenoviruses may be part of
their normal ﬂora.Table 1
Neutralizing activity titers (IC90)n of animal sera.
Virus
Serum GC44 GC45 GC46
GC44 461 o16 o16
GC45 o16 922 o16
GC46 18 o16 410
n IC90¼90% inhibitory concentration.Growth on human cell lines
The viruses that were propagated from the plasmid clones
were grown in suspension cultures of the human cell line 293-
ORF6 and puriﬁed with cesium chloride isopycnic density centri-
fugation and dialysis against Final Formulation Buffer (McVey
et al., 2010). The yields of highly puriﬁed virus particles (pu) of
GC46 was 59,819 pu/cell (n¼2), of GC45 was 45,454 pu/cell (n¼3),
and of GC44 was 8468 pu/cell (n¼1). In a single-burst experiment
the GC46 wild type virus replicated to high titers on 293-ORF6 and
293 cells (Fig. 2). GC46 was also tested for growth on the lung
carcinoma cell line A549 and the production of viral progeny was
comparable to that on the two adenovirus-complementing cell
lines (Fig. 2).
To initially evaluate the utility of the new viruses as gene transfer
vectors, viruses with deletions were generated. The viral vectors
were designed and constructed using standard methods (Kahl et al.,
2010; Lemiale et al., 2007; McVey et al., 2010). The deletions removed
the open reading frames of E1A and E1B with the insertion of an
expression cassette consisting of the CMV promoter, the luciferase
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grew efﬁciently to high titer, comparable to GC46 wild type, on the
adenovirus-complementing cell lines 293 and 293-ORF6, but growth
on A549 cells was ≥1000-fold lower with viral concentrations at or
below the limit of quantitation (Fig. 2). Therefore, the three GC
viruses replicated efﬁciently on human cell lines, E1-deleted viral
vectors were replication-deﬁcient, and the adenovirus complement-
ing cell lines provided full functional complementation. Additionally,
a GC46 viral vector with deletion of E1 and E4 regions was
constructed and analyzed for growth on 293 and 293-ORF6 cell
lines. E1-deleted GC46 vectors with a deletion of the entire E4 region
grew to high titers on only the E1 and E4 complementing cell line
293-ORF6 (unpublished data), demonstrating that both E1 and E4 are
essential for growth of GC46.
Cell binding
To further characterize the new adenoviruses we investigated
virus–cell binding. Binding inhibition by puriﬁed Ad5 ﬁber knob
was determined for GC46. Two micrograms of Ad5 ﬁber knob
(His-tagged, baculovirus expressed, and puriﬁed over cobalt con-
taining resin) was incubated with 50,000 293 cells in a 96 well
format on ice for an hour. The medium was aspirated and 500 pu/
cell of luciferase vectors GC46(E1-E4-), Ad5(E1-E4-), or Ad35(E1-
E4-), was added and incubated on ice for 1 h. The media was
removed, cells fed with DMEM+10% fetal bovine serum, placed at
37 1C, and luciferase activity measured the next day. As noted
above, E1-, E4-deleted viruses do not replicate on 293 cells.
Binding inhibitions were conducted in triplicate and the results
from one experiment are shown in Fig. 3. As expected the ﬁber
knob blocked Ad5 transduction (85%) but had no effect on Ad35,
which uses CD46 as its receptor (Fig. 3). GC46 transduction was
signiﬁcantly reduced (73%, po0.05 t-test). These data demon-
strate that Ad5 ﬁber knob, which binds to the receptor CAR,
prevents GC46 from infecting these cells. Hemagglutination was
not tested, but based on the blocking of binding by Ad5 ﬁber; it is
likely that the ﬁber proteins of the gorilla adenoviruses would
partially agglutinate rat erythrocytes in the same fashion as the
human adenoviruses of species C.Conclusion
These data are consistent with the three gorilla adenoviruses as
distinct types and belonging within the human species C grouping.
Species C adenoviruses including chimpanzee adenovirus 3 and
human adenoviruses 5 and 6 have been effective vaccine vectors in
animal models. The three gorilla adenoviruses described in this
report are different from the human and chimpanzee adenoviruses
as illustrated by the phylogenetic reconstructions. The molecular
cloning of the three gorilla species C adenoviruses will facilitate
the characterization of the viruses, both as pathogens and as viral
vectors. Vaccine vectors derived from the three gorilla adeno-
viruses are currently being evaluated.
NCBI sequence accession numbers
GC44: hexon KC702813; DNA polymerase KC702816; E4 ORF6
KC702819. GC45: hexon KC702814; DNA polymerase KC702817;
E4 ORF6 KC702820. GC46: hexon KC702815; DNA polymerase
KC702818; E4 ORF6 KC702820. NCBI nucleotide sequence
accession numbers for phylogenetic analyses: HAdV-1
AC000017; HAdV-2 NC001405; HAdV-5 AC000008; HAdV-6
DQ149613; HAdV-F NC001454; HAdV-A NC001460; HAdV-B1
NC011203; HAdV-B2 NC011202; HAdV-D NC010956; HAdV-E
NC003266; HAdV-G NC006879; SAdV-31.1 FJ025906; SAdV-31.2FJ025904; SAdV-34 FJ025905; SAdV-40.2 FJ025926; SAdV-40.1
FJ025907; SAdV-44 FJ025899; SAdV-42.3 FJ025925; SAdV-42.2
FJ025902; SAdV-42.1 FJ025903; SAdV-43 FJ025900; SAdV-45
FJ025901; BAdV-3 AF030154; GgorAdV-6 (hexon gene only)
JN163985; PtroAdV-9 JN163979 (hexon gene only); PtroAdV-6
JN163976; PtroAdV-4 JN163974;.Acknowledgments
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